Scott Rocklage rose to the level of a Managing Partner within the first year working at the Venture Capitalist firm, 5AM Ventures Inc. The revered researcher, Dr. Scott spent over thirty plus years, leading some of America’s leading pharmaceutical giants.
Scott M. Rocklage, Ph.D. is an accomplished research professor who’s played an instrumental role in the successful development of drugs that ended up saving millions of lives, the world over.
Rocklage led a research team of scientists who developed the FDA approved drug applications retailing worldwide under the following generic labels: Cubicin, Teslascan, and Omniscan.
President and CEO, Scott Rocklage
Scott M. Rocklage, Ph.D. has previously served as the Chairman, CEO or President of the following publicly traded biotechnology research institutes and pharmaceutical companies. Nycomed Salutar, Cubic Pharmaceuticals, Catalytica, Relypsa, Rennovia, Pulmatric, Novira and at Cidara the Nasdaq pharmaceutical giant trading under the initials CDTX.
Professor Scott studied for his undergraduate degree at UCLA’s Berkeley University. Dr. Scott graduated with a first-class Bachelor of Science degree in Chemistry. He would eventually pursue his masters and Ph.D. in drug research and development at the respected MIT.
Professor Scott is said to have shared laboratory premises with the 2005 Chemistry Nobel Prize winner, Professor. Richard R. Schrock.
Published Medical Journals
The eminent researcher, Dr. Scott Rocklage has published a ton of medical groundbreaking research findings over the decades. The over 30 U.S Medical patents to his name are a clear testament to Dr. Scott’s immense contribution to the pharmaceutical realm. Read more: Scott Racklage | Bloomberg
Recently, MIT erected a plaque in honor of the lifetime achievements of Professor Scott. The scientists graced the auspicious event accompanied by his lifetime lover and wife.
Interview with Dr. Scott Rocklage
According to a candid interview with Ideamensch.com, Scott Rocklage offers remarkable advice to aspiring investors and entrepreneurs. Scott Rocklage comes across as a very organized individual who takes great pride in investing in skilled people.
He reminds us of the value and importance of staying true to the course no matter the prevailing circumstances.
The problem, according to Scott, with many aspiring investors is that they tend to focus on the short-term instead of paying emphasis on the long-term goals and objectives of the business.
His advice to us is that we ought to take bold but calculated risks and make sure we have the right team and the rest falls into place just perfectly.